Diagnostic potential of nanoparticle aided assays for <scp>MUC16</scp> and <scp>MUC1</scp> glycovariants in ovarian cancer-Reference-Cited by-同舟云学术

Diagnostic potential of nanoparticle aided assays for MUC16 and MUC1 glycovariants in ovarian cancer

Published:2022-05-25 Issue:7 Volume:151 Page:1175-1184
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Intl Journal of Cancer

Author:

Jain Shruti¹^ORCID,Nadeem Nimrah¹,Ulfenborg Benjamin²,Mäkelä Maria¹,Ruma Shamima Afrin¹,Terävä Joonas¹^ORCID,Huhtinen Kaisa³⁴,Leivo Janne¹^ORCID,Kristjansdottir Björg⁵,Pettersson Kim¹,Sundfeldt Karin⁵^ORCID,Gidwani Kamlesh¹^ORCID

Affiliation:

1. Department of Life Technologies and FICAN West Cancer Centre University of Turku Turku Finland

2. Systems Biology Research Centre, School of Bioscience University of Skövde Skövde Sweden

3. Institute of Biomedicine and FICAN West Cancer Centre University of Turku and Turku University Hospital Turku Finland

4. Systems Oncology, Research Programs Unit, Faculty of Medicine University of Helsinki Helsinki Finland

5. Department of Obstetrics and Gynecology, Institute of Clinical Sciences, Sahlgrenska Center for Cancer Research University of Gothenburg Gothenburg Sweden

Funder

Jane ja Aatos Erkon Säätiö

Swedish Cancer Foundation

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ijc.34111

Reference50 articles.

1. Global surveillance of cancer survival 1995–2009: analysis of individual data for 25 676 887 patients from 279 population-based registries in 67 countries (CONCORD-2)

2. High throughput proteomics identifies a high-accuracy 11 plasma protein biomarker signature for ovarian cancer